WA
AMED

Whipplewood Advisors’s Amedisys AMED Stock Holding History

Whipplewood Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$689 – 339
2025
Q2 		$689 Sell
7
-14
-67% -$1.32K ﹤0.01% 1079
2025
Q1 		$2.5K Sell
21
-6
-22% -$553 ﹤0.01% 838
2024
Q4 		$2.45K Buy
+27
New +$2.48K ﹤0.01% 835

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Whipplewood Advisors's AMED Position: Q3 2025 in Review

Whipplewood Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7 shares — an estimated $689 sold.

Whipplewood Advisors first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $2.5K in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Whipplewood Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Whipplewood Advisors sold 7 Amedisys shares in Q3 2025, an estimated $689.
  • Whipplewood Advisors first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
  • Whipplewood Advisors's Amedisys position peaked at $2.5K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Whipplewood Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.